XML 33 R22.htm IDEA: XBRL DOCUMENT
v3.23.1

Stockholders' Equity | 3 Months Ended
--- | ---
Mar. 31, 2023
Stockholders' Equity |
Stockholders' Equity | Note 15. Stockholders' Equity ​ Share Buyback Program ​ Pursuant to the Company’s existing share buyback program, the Company purchased 263,131 and 51,168 shares of its common stock during the three months ended March 31, 2023 and 2022, totaling $8.0 million and $1.2 million, respectively. ​ In November 2022, the Company’s Board of Directors authorized a $50.0 million increase to the Company’s share buyback program, which is expected to continue for an indefinite period of time. Since the inception of the program, the Company’s Board of Directors have authorized a total of $235.0 million in the share buyback program. The primary goal of the program is to offset dilution created by the Company’s equity compensation programs. ​ Purchases are made through open market and private block transactions pursuant to Rule 10b5-1 plans, privately negotiated transactions or other means as determined by the Company’s management and in accordance with the requirements of the SEC and applicable laws. The timing and actual number of treasury share purchases will depend on a variety of factors including price, corporate and regulatory requirements, and other conditions. These treasury share purchases are accounted for under the cost method and are included as a component of treasury stock in the Company’s condensed consolidated balance sheets. ​ Amended and Restated 2015 Equity Incentive Plan ​ As of March 31, 2023, the Company reserved an aggregate of 6,833,188 shares of common stock for future issuance under the Amended and Restated 2015 Equity Incentive Plan, or the 2015 Plan, including 1,202,802 shares, which were reserved in January 2023 pursuant to the evergreen provision in the 2015 Plan. ​ 2014 Employee Stock Purchase Plan ​ As of March 31, 2023, the Company has issued 1,089,545 shares of common stock under the ESPP and 910,455 shares of its common stock remain available for issuance under the ESPP. ​ For the three months ended March 31, 2023 and 2022, the Company recorded ESPP expense of $0.3 million and $0.2 million, respectively. ​ Share-Based Award Activity and Balances ​ The Company accounts for share-based compensation payments in accordance with ASC 718, which requires measurement and recognition of compensation expense at fair value for all share-based payment awards made to employees and directors. Under these standards, the fair value of option awards and the option components of the ESPP awards are estimated at the grant date using the Black-Scholes option-pricing model. The fair value of RSUs is estimated at the grant date using the Company’s common share price. Compensation cost for all share-based payments granted with service-based graded vesting schedules is recognized using the straight-line method over the requisite service period. ​ The weighted-averages for key assumptions used in determining the fair value of options granted during the three months ended March 31, 2023 and 2022, are as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​ | ​
​ | ​ | March 31, | ​ | ​
​ |  | 2023 |  | 2022 |  | ​
Average volatility |  | 41.5 | % | 41.1 | % | ​
Average risk-free interest rate |  | 4.2 | % | 2.2 | % | ​
Weighted-average expected life in years |  | 6.3 | ​ | 6.3 | ​ | ​
Dividend yield rate |  | — | % | — | % | ​
​ A summary of option activity under all plans for the three months ended March 31, 2023, is presented below: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Weighted-Average | ​ | ​ | ​ |
​ | ​ | ​ | ​ | Weighted-Average | ​ | Remaining | ​ | Aggregate |
​ | ​ | ​ | ​ | Exercise | ​ | Contractual | ​ | Intrinsic |
​ | ​ | Options | ​ | Price | ​ | Term (Years) | ​ | Value(1) |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (in thousands) |
Outstanding as of December 31, 2022 | ​ | 7,929,150 | ​ | $ | 17.66 |  |  |  | ​ |  | ​
Options granted | ​ | 700,601 | ​ | ​ | 35.13 | ​ | ​ | ​ | ​ | ​ | ​
Options exercised | ​ | (102,024) | ​ | ​ | 13.61 | ​ | ​ | ​ | ​ | ​ | ​
Options forfeited | ​ | (1,601) | ​ | ​ | 31.21 | ​ | ​ | ​ | ​ | ​ | ​
Options expired | ​ | — | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | ​
Outstanding as of March 31, 2023 | ​ | 8,526,126 | ​ | $ | 19.15 | ​ | 5.15 | ​ | ​ | 156,491 | ​
Exercisable as of March 31, 2023 | ​ | 6,376,523 | ​ | $ | 16.25 | ​ | 3.94 | ​ | ​ | 135,510 | ​
Vested and expected to vest as of March 31, 2023 | ​ | 8,270,035 | ​ | $ | 18.83 | ​ | 5.03 | ​ | ​ | 154,400 | ​
(1) | The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the estimated fair value of the Company’s stock for those awards that have an exercise price below the estimated fair value at March 31, 2023.
​ For the three months ended March 31, 2023 and 2022, the Company recorded expense of $3.0 million and $2.5 million, respectively, related to stock options granted under all plans. ​ Information relating to option grants and exercises is as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended |
​ | ​ | March 31, | ​
​ |  | 2023 |  | 2022 |
​ | ​ | (in thousands, except per share data) |
Weighted-average grant date fair value per option share | ​ | $ | 16.67 | ​ | $ | 15.06 | ​
Intrinsic value of options exercised | ​ |  | 2,341 | ​ |  | 12,200 | ​
Cash received from options exercised | ​ |  | 1,388 | ​ |  | 12,450 | ​
Total fair value of the options vested during the period | ​ |  | 7,584 | ​ |  | 6,987 | ​
​ A summary of the status of the Company’s non-vested options as of March 31, 2023, and changes during the three months ended March 31, 2023, are presented below: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Weighted-Average |
​ | ​ | ​ | ​ | Grant Date |
​ | ​ | Options | ​ | Fair Value |
Non-vested as of December 31, 2022 | ​ | 2,378,453 | ​ | $ | 9.48 | ​
Options granted |  | 700,601 | ​ | ​ | 16.67 | ​
Options vested |  | (927,850) | ​ | ​ | 8.17 | ​
Options forfeited |  | (1,601) | ​ | ​ | 13.96 | ​
Non-vested as of March 31, 2023 |  | 2,149,603 | ​ |  | 12.39 | ​
​ As of March 31, 2023, there was $21.4 million of total unrecognized compensation cost, net of forfeitures, related to non-vested stock option based compensation arrangements granted under all plans. The cost is expected to be recognized over a weighted-average period of 3.1 years and will be adjusted for future changes in estimated forfeitures. ​ Restricted Stock Units ​ The Company grants restricted stock units, or RSUs, to certain employees and members of the Board of Directors with a vesting period of up to five years. The grantee receives one share of common stock at a specified future date for each RSU awarded. The RSUs may not be sold or otherwise transferred until vested. The RSUs do not have any voting or dividend rights prior to the issuance of certificates of the underlying common stock. The share-based expense associated with these grants was based on the Company’s common stock fair value at the time of grant and is amortized over the requisite service period, which generally is the vesting period using the straight-line method. For the three months ended March 31, 2023 and 2022, the Company recorded expenses of $2.9 million and $2.4 million, respectively, related to RSU awards granted under all plans. ​ As of March 31, 2023, there was $22.6 million of total unrecognized compensation cost, net of forfeitures, related to non-vested RSU based compensation arrangements granted under all plans. The cost is expected to be recognized over a weighted-average period of 3.1 years and will be adjusted for future changes in estimated forfeitures. ​ Information relating to RSU grants and deliveries is as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Total Fair Market |
​ | ​ | Total RSUs | ​ | Value of RSUs |
​ |  | Issued |  | Issued(1) |
​ | ​ | ​ | ​ | (in thousands) |
RSUs outstanding at December 31, 2022 |  | 1,007,052 | ​ | ​ | ​ | ​
RSUs granted |  | 332,247 | ​ | $ | 11,672 | ​
RSUs forfeited |  | (705) | ​ | ​ | ​ | ​
RSUs vested(2) |  | (389,250) | ​ | ​ | ​ | ​
RSUs outstanding at March 31, 2023 |  | 949,344 | ​ | ​ | ​ | ​
(1) | The total fair market value is derived from the number of RSUs granted times the current stock price on the date of grant.
(2) | Of the vested RSUs, 160,974 shares of common stock were surrendered to fulfil tax withholding obligations.
​ Share-based Compensation Expense ​ The Company recorded share-based compensation expense, which is included in the Company’s condensed consolidated statement of operations as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended
​ | ​ | March 31,
​ | ​ | 2023 | ​ | 2022
​ | ​ | (in thousands)
Cost of revenues |  | $ | 1,706 |  | $ | 1,385
Operating expenses: | ​ | ​ | ​ | ​ | ​ | ​
Selling, distribution, and marketing | ​ |  | 209 | ​ |  | 168
General and administrative | ​ |  | 3,357 | ​ |  | 2,861
Research and development | ​ |  | 839 | ​ |  | 608
Total share-based compensation | ​ | $ | 6,111 | ​ | $ | 5,022
​

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI https://asc.fasb.org/topic&trid=2208762 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (g) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (h) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 16 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (i) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 40 -Section 50 -Paragraph 6 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration